P. Bruzzi

发表

Geographical variations of place of death among Italian communities suggest an inappropriate hospital use in the terminal phase of cancer disease.

M. Costantini, D. Balzi, E. Garronec, 2000, Public health.

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

K. S. Hall, J. Blay, V. Torri, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement

P. Bruzzi, M. T. Ricci, S. Sciallero, 2015, Public Health Genomics.

Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)

D. Weisenburger, E. Greiser, A. Biggeri, 2016, Journal of Epidemiology & Community Health.

CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence

M. Pistillo, M. Gobbi, P. Bruzzi, 2010, Annals of Hematology.

Comparative Evaluation of Autologous Chondrocyte Implantation and Mosaicplasty: A Multicentered Randomized Clinical Trial

R. Cancedda, M. Marcacci, P. Bruzzi, 2005, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

Major and minor salivary glands tumours.

P. Bruzzi, J. Schornagel, L. Licitra, 2003, Critical reviews in oncology/hematology.

MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials

M. Sormani, P. Bruzzi, 2013, The Lancet Neurology.

Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer.

M. C. Martina, E. Neri, C. Bartolozzi, 2009, JAMA.

Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alteration.

C. Campi, M. Piana, P. Bruzzi, 2014, Radiology.

Novel germline APC variants in patients with multiple adenomas

P. Bruzzi, P. Stagnaro, J. Groden, 1998, Genes, chromosomes & cancer.

Estimating the population attributable risk for multiple risk factors using case-control data.

D P Byar, S B Green, D. Byar, 1985, American journal of epidemiology.

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta‐analytic approach

Luca Roccatagliata, Paolo Bruzzi, Laura Bonzano, 2009, Annals of neurology.

Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.

Ruth Ladenstein, Adela Cañete, Victoria Castel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

P. Bruzzi, B. Bernardi, Y. Rycke, 2008, British Journal of Cancer.

Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.

A. Donfrancesco, P. Bruzzi, G. Tonini, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases.

A. Donfrancesco, P. Bruzzi, M. Carli, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.

P. Bruzzi, C. Viscoli, D. Giacobbe, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

P. Bruzzi, M. Bassetti, C. Viscoli, 2011, Clinical and Vaccine Immunology.

A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility

P. Bruzzi, S. Morbelli, A. Gallamini, 2017, Diagnostics.

Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).

C. Boni, F. di Costanzo, M. Tonato, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy

O. Nanni, E. Scarpi, D. Amadori, 2016, Breast Cancer Research and Treatment.

Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation

P. Bruzzi, A. Ibatici, S. Morbelli, 2017, The Journal of Nuclear Medicine.

Value of Multiple Forceps Biopsies in Assessing the Malignant Potential of Colonic Polyps

P. Bruzzi, H. Aste, G. Nicolò, 1981, Tumori.

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer.

M. Costantini, P. Bruzzi, A. Ardizzoni, 1990, European journal of cancer.

Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014)

K. S. Hall, J. Blay, V. Torri, 2015 .

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

P. Bruzzi, C. Viscoli, A. Bacigalupo, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case‐control study

P. Bruzzi, H. Aste, M. Conio, 1988, International journal of cancer.

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

S. Barni, P. Bruzzi, M. Ceppi, 2017, European journal of cancer.

Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole

P. Bruzzi, F. Puglisi, R. Ponzone, 2012, Breast Cancer Research and Treatment.

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

C. Orlandini, P. Bruzzi, T. Prochilo, 2004, British Journal of Cancer.

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

P. Bruzzi, C. Maggioni, F. Grossi, 2019, Journal of clinical medicine.

TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex

P. Bruzzi, R. Touraine, V. Cottin, 2014, Orphanet Journal of Rare Diseases.

Activity of 4‐HPR in superficial bladder caner using DNA flow cytometry as an intermediate endpoint

Alberto Costa, M. Costantini, P. Bruzzi, 1992 .

Sentinel lymph node biopsy in patients with malignant melanoma: analysis of post‐operative complications

P. Bruzzi, N. Solari, F. Cafiero, 2019, ANZ journal of surgery.

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies.

M. Sormani, P. Bruzzi, L. Ferrari, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metabolic Treatment with L-Carnitine in Acute Anterior ST Segment Elevation Myocardial Infarction

S. Iliceto, P. Rizzon, P. Bruzzi, 2006, Cardiology.

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.

P. Sismondi, I. Nenci, P. Bruzzi, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients.

P. Bruzzi, F. Boccardo, A. Rubagotti, 1981, Oncology.

Divergent determinants of 18F–NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score

A. Alavi, P. Bruzzi, A. Piccardo, 2014, The International Journal of Cardiovascular Imaging.

Body Mass Index and Prognosis of Metastatic Breast Cancer Patients Receiving First-Line Chemotherapy

O. Nanni, E. Scarpi, D. Amadori, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Risk factors for breast cancer: pooled results from three Italian case-control studies.

C. la Vecchia, E. Negri, P. Bruzzi, 1988, American journal of epidemiology.

Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study

P. Bruzzi, C. Bolognesi, S. Pavanello, 2018, PloS one.

Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial

N. Biglia, M. Scorsetti, P. Bruzzi, 2022, Annals of Surgical Oncology.

REDUCTION OF THE INCIDENCE OF METACHRONOUS ADENOMAS OF THE LARGE BOWEL BY MEANS OF ANTIOXIDANTS: A DOUBLE BLIND RANDOMIZED TRIAL

J. Salonen, P. Bruzzi, J. Kumpulainen, 1999 .

Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial

O. Nanni, D. Amadori, L. Cavanna, 2020, Breast Cancer Research and Treatment.

Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway

C. Campi, M. Cilli, M. Piana, 2017, Scientific Reports.

Regional Differences in Rates of Diagnosis and Mortality of Pulmonary Thromboembolism

N. Jersey., P. Bruzzi, L. Monserrat, 2004 .

Bevacizumab plus fluorouracil: the value of being part of a developing story.

P. Bruzzi, A. Sobrero, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.

S. Barni, R. Labianca, L. Frontini, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

F. di Costanzo, P. Bruzzi, L. Dogliotti, 2005, British Journal of Cancer.

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

P. Bruzzi, F. Costanzo, L. Dogliotti, 2004, British Journal of Cancer.

Vatalanib in advanced colorectal cancer: two studies with identical results.

P. Bruzzi, A. Sobrero, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Methodological and ethical difficulties in clinical oncology trials

P. Bruzzi, R. Raschetti, 1999, The Lancet.

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

K. S. Hall, J. Blay, Torri, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

P. Bruzzi, M. Lambertini, F. Poggio, 2016, Supportive Care in Cancer.

Quality of life assessment and clinical decision-making.

M. Costantini, P. Bruzzi, A. Santoro, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

The Relationship Between Oral Contraceptive Use, Cancer and Vascular Disease

S. Franceschi, P. Boyle, P. Bruzzi, 1990, Drug safety.

Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis

P. Bruzzi, S. Ferrero, S. Mammoliti, 2020, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

P. Bruzzi, S. Morbelli, G. Sambuceti, 2019 .

Hodgkin's disease in adults: Association with social factors and age at tonsillectomy. A case‐control study

V. Vitale, P. Bruzzi, L. Bonelli, 1990, International journal of cancer.

An Estimate of Prostate Cancer Prevalence in Italy

C. la Vecchia, P. Boyle, P. Bruzzi, 2002, Tumori.

Neo-Adjuvant Chemo/Immunotherapy in the Treatment of Stage III (N2) Non-Small Cell Lung Cancer: A Phase I/II Pilot Study

P. Bruzzi, B. Dozin, G. Tripodi, 2011, International journal of immunopathology and pharmacology.

Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?

P. Bruzzi, B. Dozin, P. Maineri, 2009, The Journal of thoracic and cardiovascular surgery.

Short Hydration Regimen and Nephrotoxicity of Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient Treatment in Lung Cancer and Mesothelioma

M. Sormani, F. de Marinis, P. Bruzzi, 2007, Tumori.

Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial

M. Massari, A. Pan, S. Nava, 2022, European Respiratory Journal.

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments

P. Bruzzi, D. Merlo, F. Cognetti, 2013, BMC Cancer.

BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B.

M. Sormani, P. Bruzzi, P. Vigneri, 2006, Blood.

Carcinogenicity study with technical-grade dichlorodiphenyltrichloroethane and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene in hamsters.

P. Bruzzi, L. Santi, O. Barbieri, 1983, Cancer research.

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.

M. Filippi, P. Bruzzi, G. Mancardi, 2005, Blood.

Cytokeratin immunostaining reveals micrometastasis in negative hematoxylin-eosin lymph nodes of resected stage I-II (pT2-pT3) colorectal cancer.

P. Bruzzi, C. Gambini, S. Sciallero, 1997, Journal of chemotherapy.

Body mass index and post-menopausal breast cancer: an age-specific analysis.

C. la Vecchia, E. Negri, S. Franceschi, 1997, British Journal of Cancer.

[A controlled-case study on risk factors in tumors of the oral cavity. Perspectives and indications for early diagnosis].

P. Bruzzi, G. Margarino, M. Scala, 1983, Minerva medica.

Breast Cancer Risk Factors in Italian Women: A Multicentric Case-Control Study

D. Amadori, S. Ciatto, M. R. del Turco, 1986, Tumori.

Socioeconomic characteristics, life style, diabetes, family history of cancer and risk of pancreatic cancer

P. Bruzzi, S. Sciallero, L. Bonelli, 1993 .

Prevalence of Prostate Cancer at Different Clinical Stages in Italy: Estimated Burden of Disease Based on a Modelling Study

P. Bruzzi, R. Iacovelli, F. Spandonaro, 2021, Biology.

A randomized trial of adoptive immunotherapy with tumor‐infiltrating lymphocytes and interleukin‐2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

P. Bruzzi, G. Melioli, G. Ratto, 1996, Cancer.

Correlation between steroid hormone receptors and prognostic factors in human breast cancer.

P. Bruzzi, G. Barbi, G. Nicolò, 1987, Oncology.

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients

P. Bruzzi, R. Rosso, M. Venturini, 2005, British Journal of Cancer.

Objective Response to Treatment as a Potential Surrogate Marker of Survival in Breast Cancer

P. Bruzzi, 2002, Annals of the New York Academy of Sciences.

Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.

S. Iliceto, P. Rizzon, P. Bruzzi, 1995, Journal of the American College of Cardiology.

Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making?

P. Bruzzi, M. Bobbio, L. Pagliaro, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018

P. Ascierto, A. Testori, H. Tawbi, 2019, Journal of Translational Medicine.

Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo.

P. Bruzzi, C. Viscoli, G. Icardi, 2015, The new microbiologica.

Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.

C. Orlandini, P. Bruzzi, R. Danesi, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unanswered Issues in Low-Level Chemical Pollution: The Case of Dioxins and Related Compounds

L. Bisanti, P. Bruzzi, R. Raschetti, 1985 .

Adjuvant mitotane treatment for adrenocortical carcinoma.

M. Papotti, P. Bruzzi, M. Fassnacht, 2007, The New England journal of medicine.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

P. Bruzzi, A. Bosi, T. Lamparelli, 2001, Blood.

Proportion of gastric cancer risk attributable to diet in Italy

D. Amadori, W. Blot, S. Bianchi, 1991 .

Some Further Consideration on the Role of Oral Contraceptives in Breast Carcinogenesis

C. la Vecchia, P. Bruzzi, Peter Boyle, 1990, Tumori.

Risk associated with pregnancy in hypertrophic cardiomyopathy.

C. Autore, P. Bruzzi, P. Spirito, 2002, Journal of the American College of Cardiology.

Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes.

P. Bruzzi, F. Schittulli, A. Iolascon, 2003, Clinical chemistry.

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

M. Massari, M. Costantini, P. Bruzzi, 2020, JAMA internal medicine.

Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion

N. Scopinaro, G. Adami, P. Bruzzi, 2017, Obesity Surgery.

one SNP at a time with the new software (PSQHS 96A) from Pyrosequencing AB is likely to speed up haplotype analysis. When pyrosequencing data for DPYD*5, DPYD*2A, DPYD*9A, and DPYD*6 were analyzed using the Polymorphism Haplotype Analysis Suite (PHASE),

P. Bruzzi, F. Schittulli, F. Ragione, 2003 .

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

C. R. Leemans, J. Machiels, P. Bruzzi, 2019, Journal of Immunotherapy for Cancer.

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

L. V. van't Veer, S. Fox, C. Sotiriou, 2011, Journal of the National Cancer Institute. Monographs.

N. Biglia, M. Scorsetti, P. Bruzzi, 2022, Annals of Surgical Oncology.

Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study.

P. Bruzzi, M. Benasso, L. Licitra, 2019, Oral oncology.

The sacral chordoma margin.

P. Georg, P. Navarria, D. Campanacci, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.

P. Bruzzi, M. Arosio, F. Minuto, 2001, The Journal of clinical endocrinology and metabolism.

Role of Preoperative Cardiovascular Magnetic Resonance in Planning Ventricular Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

P. Bruzzi, A. Mortara, G. Vaccari, 2019, The American journal of cardiology.

Effect of a palliative home care team on hospital admissions among patients with advanced cancer

I. Higginson, M. Costantini, P. Bruzzi, 2003, Palliative medicine.

Randomized Study Comparing Chemotherapy Plus Radiotherapy Versus Radiotherapy Alone in FIGO Stage IIB‐III Cervical Carcinoma

P. Franzone, V. Vitale, P. Bruzzi, 1994 .

A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer

P. Bruzzi, L. Boni, C. Viscoli, 2003, The Pediatric infectious disease journal.

A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

P. Bruzzi, C. Vancheri, M. Bassetti, 2021, Infectious Disease and Therapy.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

P. Bruzzi, A. Bosi, T. Lamparelli, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly.

P. Bruzzi, F. Minuto, F. Camanni, 1989, Acta endocrinologica.

Original article: The role of age at menarche and at menopause on breast cancer risk: Combined evidence from four case-control studies

E. Negri, S. Franceschi, R. Talamini, 1992 .

The role of age at menarche and at menopause on breast cancer risk: combined evidence from four case-control studies.

C. la Vecchia, E. Negri, S. Franceschi, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Short title for running head: management of cutaneous B-cell lymphoma

E. Noordijk, L. Cerroni, P. Bruzzi, 2008 .

Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5‐fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy

P. Bruzzi, O. Garrone, R. Rosso, 1994, Cancer.

Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation

M. Sormani, P. Bruzzi, P. Pedrazzoli, 2005, Cancer.

Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy

P. Bruzzi, L. Merlini, P. Conte, 1995 .

A phase II comparative study of metformin plus first-line chemotherapy (CT) versus CT alone in HER2-negative, insulin-resistant (IR), nondiabetic metastatic breast cancer (MBC).

O. Nanni, D. Amadori, P. Bruzzi, 2010 .

375 Effect of adjuvant chemotherapy (ACT) with or without anthracyclines on first line CEF in metastatic breast cancer patients (PTS)

P. Bruzzi, O. Garrone, G. Bertelli, 1995 .

Estimating a treatment effect: Choosing between relative and absolute measures

M. Sormani, P. Bruzzi, 2017, Multiple sclerosis.

Menstrual patterns, fertility and main pregnancy outcomes after allogeneic haematopoietic stem cell transplantation

P. Bruzzi, A. Bacigalupo, P. Anserini, 2016, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia

P. Bruzzi, P. Queirolo, P. Ghiorzo, 1999, International journal of cancer.

Cohort study of women affected by gross cystic disease. Correlation between cationic and hormonal composition of breast cyst fluid and the risk of breast cancer.

P. Bruzzi, C. Naldoni, L. Bucchi, 1990, Annals of the New York Academy of Sciences.

Follow‐up Studies of Patients with Categorized Breast Cysts

M. Costantini, P. Bruzzi, C. Naldoni, 1990, Annals of the New York Academy of Sciences.

Congenital Muscular Mitral-Aortic Discontinuity Identified in Patients With Obstructive Hypertrophic Cardiomyopathy.

P. Bruzzi, A. Mortara, L. Boni, 2020, Journal of the American College of Cardiology.

Comments on “evidence for acute neurotoxicity after chemotherapy”

M. Sormani, P. Bruzzi, G. Mancardi, 2011, Annals of neurology.

Cardiomyopathy and Pregnancy Risk Associated With Pregnancy in Hypertrophic Cardiomyopathy

C. Autore, P. Bruzzi, P. Spirito, 2002 .

Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700)

P. Bruzzi, R. Corvò, M. Benasso, 2020, Oncology.

Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients

P. Bruzzi, O. Garrone, M. Merlano, 2016, OncoTarget.

SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes.

P. Bruzzi, B. Dozin, G. Canavese, 2016, Breast.

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.

B. Maron, P. Bruzzi, K. M. Harris, 2000, The New England journal of medicine.

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy (CT) in early breast cancer (BC) patients

P. Bruzzi, R. Rosso, M. Venturini, 2004 .

Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients

P. Bruzzi, A. Ardizzoni, D. Zarcone, 1986, Cancer.

Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients

P. Bruzzi, C. Viscoli, A. Bacigalupo, 2012, Infection.

Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion.

P. Bruzzi, C. Viscoli, A. Bacigalupo, 2007, The new microbiologica.

Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments

G. Comi, M. Rovaris, M. Filippi, 2001, Neurology.

Non-drug industry funded research

P. Bruzzi, 2007, BMJ : British Medical Journal.

Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis

P. Bruzzi, C. Bolognesi, F. Cardinale, 2011, British Journal of Cancer.

Micronucleus test for radiation biodosimetry in mass casualty events: Evaluation of visual and automated scoring

E. Righi, P. Bruzzi, C. Bolognesi, 2011 .

Hematologic Parameters during Treatment with High-Dose Medroxyprogesterone Acetate

P. Bruzzi, R. Puntoni, R. Rosso, 1981, Tumori.

Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancer.

P. Bruzzi, T. Scolaro, G. Melioli, 2000, Journal of immunotherapy.

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis.

P. Bruzzi, M. Ceppi, M. Lambertini, 2017, Breast.

Methylprednisolone for the Control of CMF‐Induced Emesis

P. Bruzzi, R. Rosso, R. Lionetto, 1987, American journal of clinical oncology.

Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.

P. Bruzzi, R. Rosso, E. Campora, 1984, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Error in Title.

M. Sormani, P. Bruzzi, I. Schiavetti, 2021, JAMA ophthalmology.

Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo.

P. Bruzzi, C. Viscoli, B. Bruzzone, 2013, Journal of Antimicrobial Chemotherapy.

Interobserver agreement in the histologic diagnosis of colorectal polyps. the experience of the multicenter adenoma colorectal study (SMAC).

M. Costantini, P. Bruzzi, G. Castiglione, 2003, Journal of clinical epidemiology.

A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, γ glutamyl transferase, donor type and cell dose

M. Sormani, P. Bruzzi, F. Frassoni, 2003, Bone Marrow Transplantation.

Attitude of women towards early cancer detection and estimation of the compliance to a screening program for cervix and breast cancer.

P. Bruzzi, M. Branca, L. Santi, 1996, Cancer Detection and Prevention.

Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014)

K. S. Hall, J. Blay, Torri, 2015 .

Mathematical modelling of pilot-plant photomineralization of chlorophenols in aqueous solution, by photocatalytic membranes immobilizing titanium dioxide

P. Bruzzi, H. Muntau, D. Niego, 1997 .

Mathematical modelling of photomineralization of phenols in aqueous solution, by photocatalytic membranes immobilizing titanium dioxide☆

P. Bruzzi, H. Muntau, D. Niego, 1996 .

Pilot-plant photomineralization of dichloromethane and tetrachloroethene in aqueous solution, by photocatalytic membranes immobilizing titanium dioxide and photopromoters

P. Bruzzi, H. Muntau, F. Gianturco, 1996 .

Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.

M. Pistillo, P. Bruzzi, G. Balbi, 2009, Human immunology.

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

S. Loibl, P. Bruzzi, M. Ceppi, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies

M. Sormani, P. Bruzzi, L. Paleari, 2015, Breast Cancer Research and Treatment.

Strategy for randomised clinical trials in rare cancers

K. Dear, D. Machin, P. Bruzzi, 2003, BMJ : British Medical Journal.

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.

J. Blay, J. Coindre, P. Bruzzi, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

J. Blay, J. Coindre, P. Bruzzi, 2017, The Lancet. Oncology.

CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.

P. Bruzzi, C. Viscoli, F. Frassoni, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

P. Bruzzi, C. Vancheri, M. Bassetti, 2021, Infectious Diseases and Therapy.

The general practitioner's approach to irritable bowel syndrome: from intention to practice.

P. Bruzzi, M. Bellini, C. Tosetti, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

P. A. Gardner, A. Caraceni, S. Boriani, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Effect of DNA Aneuploidy from Bladder Washings in Superficial Bladder Cancer

P. Bruzzi, S. Bruno, A. Decensi, 2007, Cancer Epidemiology Biomarkers & Prevention.

Disseminated neuroblastoma (stage IV and IV‐S) in the first year of life. Outcome related to age and stage

P. Bruzzi, E. Lanino, L. Boni, 1992, Cancer.

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Bingshu E. Chen, D. Berry, P. Fasching, 2019, The Lancet.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

A. Ganser, P. Bruzzi, A. Santoro, 2009, The Lancet. Oncology.

Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach.

G. Ippolito, P. Bruzzi, A. Mammone, 2014, The new microbiologica.

Epidermal Growth Factor in Breast Cyst Fluid : Relationship with Intracystic Cation and Androgen Conjugate Content 1

P. Bruzzi, F. Minuto, A. Barreca, 2006 .

Epidermal Growth Factor in Breast Cyst Fluid : Relationship with Intracystic

P. Bruzzi, F. Minuto, A. Barreca, 2006 .

Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.

P. Bruzzi, F. Boccardo, F. Minuto, 1988, Cancer research.

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

C. Solinas, P. Bruzzi, M. Santoni, 2020, Frontiers in Oncology.

Will Rogers phenomenon in multiple sclerosis

M. Rovaris, M. Filippi, À. Rovira, 2008, Annals of neurology.

Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain.

E Lanino, M Bolognesi, M. Bolognesi, 2001, Blood.

Retrospective study of childhood ganglioneuroma.

P. Bruzzi, G. Tonini, C. Gambini, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

210 Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients

P. Bruzzi, A. Sardo, O. Garrone, 2015 .

Identification of a Prognostic Signature Based on the Expression of Genes Related to the Insulin Pathway in Early Breast Cancer

M. Sormani, P. Bruzzi, A. Amaro, 2020, Breast Care.

Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast

P. Bruzzi, L. Dogliotti, C. Naldoni, 1997, BMJ.

Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk

P. Bruzzi, L. Dogliotti, C. Naldoni, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.

M. Costantini, P. Bruzzi, L. Dogliotti, 1992, Cancer research.

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

P. Bruzzi, D. Generali, M. Brizzi, 2001, British Journal of Cancer.

Anticancer innovative therapy congress: Highlights from the 10th anniversary edition.

D. Schadendorf, S. Bicciato, L. Magnani, 2021, Cytokine & growth factor reviews.

An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.

P. Bruzzi, C. Viscoli, M. Glauser, 1995, European journal of cancer.

Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.

P. Bruzzi, G. Dini, L. Boni, 1991, Reviews of infectious diseases.

Combined regimen of cisplatin, doxorubicin, and α‐2b interferon in the treatment of advanced malignant pleural mesothelioma

P. Bruzzi, M. Alloisio, A. Santoro, 2001 .

Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).

P. Bruzzi, M. Alloisio, A. Santoro, 2001, Cancer.

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

P. Bruzzi, G. Tonini, B. Bernardi, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.

P. Bruzzi, M. Ceppi, T. Calandra, 2018, The Journal of infection.

Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients.

S. Fox, A. Harris, P. Bruzzi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

M. Coleman, M. Piccart, V. Torri, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomas.

P. Radice, P. Bruzzi, A. Viel, 2002, Genetic testing.

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

A. Luini, M. Cazzaniga, B. Bonanni, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.

P. Bruzzi, M. Ceppi, M. Lambertini, 2014, Cancer treatment reviews.

Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial

P. Bruzzi, E. Garrone, B. Dozin, 2016, Annals of Surgical Oncology.

Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.

L. Baglietto, M. Costantini, P. Bruzzi, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy

P. Bruzzi, M. Fiorelli, V. del Bono, 1989, Journal of clinical microbiology.

Cancer of the oropharynx.

P. Bruzzi, J. Bernier, L. Licitra, 2002, Critical reviews in oncology/hematology.

Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics.

P. Radice, P. Bruzzi, A. Viel, 2013, Breast.

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.

P. Bruzzi, F. Mosca, T. Prochilo, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination of chemotherapy and recombinant alpha‐interferon in advanced non‐small cell lung cancer: Multicentric randomized FONICAP trial report

G. Scagliotti, M. Rinaldi, F. de Marinis, 1993, Cancer.

Etoposide versus etoposide plus high‐dose cisplatin in the management of advanced non‐small cell lung cancer: Results of a prospective randomized fonicap trial

M. Rinaldi, P. Bruzzi, A. Ardizzoni, 1990 .

Raising the Bar for Antineoplastic Agents: How to Choose Threshold Values for Superiority Trials in Advanced Solid Tumors

D. Sargent, P. Bruzzi, A. Sobrero, 2014, Clinical Cancer Research.

Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval.

P. Bruzzi, A. Sobrero, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.

M. Sormani, L. Bastholt, P. Bruzzi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.

F. de Marinis, P. Bruzzi, A. Ardizzoni, 1995, British Journal of Cancer.

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

D. Bedognetti, P. Bruzzi, P. Queirolo, 2011, Journal of the National Cancer Institute.

Randomized cooperative study of perioperative chemotherapy in breast cancer.

P. Bruzzi, P. Queirolo, G. Bertelli, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Antiemetic Efficacy of Methylprednisolone Compared with Metoclopramide in Outpatients Receiving Adjuvant CMF Chemotherapy for Breast Cancer: A Randomized Trial

P. Bruzzi, R. Rosso, S. Chiara, 1985, Tumori.

Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

P. Bruzzi, S. Morbelli, G. Sambuceti, 2019, The Journal of Nuclear Medicine.

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib

P. Bruzzi, A. Ardizzoni, M. Tiseo, 2014, Cancer Chemotherapy and Pharmacology.

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma.

G. Ceresoli, F. D. De Braud, P. Bruzzi, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.

P. Scifo, F. Dell’Acqua, P. Bruzzi, 2010, European journal of cancer.

Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?

P. Bruzzi, B. De Bernardi, F. Cozzi, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

P. Bruzzi, O. Garrone, P. Conte, 2015, Breast Cancer Research and Treatment.

The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

C. Autore, P. Bruzzi, P. Spirito, 2005, Journal of the American College of Cardiology.

High expression of 90K (Mac‐2 BP) is associated with poor survival in node‐negative breast cancer patients not receiving adjuvant systemic therapies

N. Tinari, S. Iacobelli, I. Nenci, 2009, International journal of cancer.

Modelling new enhancing MRI lesion counts in multiple sclerosis

G. Comi, F. Barkhof, M. Rovaris, 2001, Multiple sclerosis.

Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials

F. Barkhof, C. Gasperini, F. Barkhof, 1999, Journal of the Neurological Sciences.

Statistical Approaches to the Use of Magnetic Resonance Imaging Data for Clinical Trials

P. Bruzzi, M. Sormani, 1999 .

An extended assessment of bowel habits in a general population.

P. Bruzzi, M. Bellini, F. Pucciani, 2004, World journal of gastroenterology.

Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.

P. Bruzzi, R. Rosso, M. Venturini, 2005, Journal of the National Cancer Institute.

NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy

P. Bruzzi, B. Dozin, G. Canavese, 2019, Contemporary clinical trials communications.

Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.

P. Bruzzi, D. Generali, M. Brizzi, 2008, The oncologist.

Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.

P. Bruzzi, E. Garrone, B. Dozin, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mortality among workers exposed to asbestos at the shipyard of Genoa, Italy: a 55 years follow-up

P. Bruzzi, M. Ceppi, D. Merlo, 2018, Environmental Health.

Refining sorafenib therapy: lessons from clinical practice.

C. Boni, P. Bruzzi, A. Santoro, 2015, Future oncology.

Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial.

G Villa, P. Bruzzi, B. Dozin, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

S. Barni, C. Boni, P. Bruzzi, 2015, The Lancet.

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.

M. Sormani, P. Bruzzi, M. Colozza, 2008, Journal of the National Cancer Institute.

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

J. Blay, J. Coindre, P. Bruzzi, 2021, Cancer.

Combined vemurafenib and fotemustine in patients with BRAFV600 melanoma progressing on vemurafenib.

P. Ascierto, E. Simeone, P. Bruzzi, 2014, Oncotarget.

Cancer of the nasopharynx.

G. Gatta, P. Bruzzi, J. Bernier, 2003, Critical reviews in oncology/hematology.

Survival of metastatic breast carcinoma patients over a 20‐year period

C. Orlandini, P. Bruzzi, P. Conte, 2005, Cancer.

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized clinical trial from the Italian Sarcoma Group, the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).

J. Blay, P. Bruzzi, P. Casali, 2019, Journal of Clinical Oncology.

Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.

P. Chanson, P. Bruzzi, F. Casanueva, 2015, European journal of endocrinology.

Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.

P. Bruzzi, A. Rubagotti, R. Rosso, 1990, Journal of chemotherapy.

Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.

P. Bruzzi, D. Merlo, A. D. Dei Tos, 2014, European journal of cancer.

Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis.

C. Autore, P. Bruzzi, C. Rapezzi, 1999, Circulation.

Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas

P. Radice, P. Bruzzi, A. Viel, 2004, International journal of cancer.

Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis

M. Filippi, M. Inglese, P. Bruzzi, 2005, Neurological Sciences.

Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures

P. Bruzzi, F. Cafiero, S. Bertoglio, 2016, Journal of surgical oncology.

Efficacy of Normal Saline Versus Heparinized Saline Solution for Locking Catheters of Totally Implantable Long-Term Central Vascular Access Devices in Adult Cancer Patients

Nicola Solari, Paolo Bruzzi, P. Bruzzi, 2012, Cancer nursing.

Benefit from letrozole as extended adjuvant therapy after sequential endocrine therapy: A randomized, phase III study of Gruppo Italiano Mammella (GIM).

P. Bruzzi, R. Ponzone, O. Garrone, 2019, Journal of Clinical Oncology.

Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials.

Mauro D'Amico, Dino Amadori, Oriana Nanni, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

O. Nanni, D. Amadori, P. Bruzzi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC)

M. Costantini, P. Bruzzi, G. Miccinesi, 2006, Journal of Epidemiology and Community Health.

Different View on Larynx Preservation Evidence-Based Treatment Recommendations.

G. Sanguineti, P. Bruzzi, L. Licitra, 2018, Journal of Clinical Oncology.

High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.

L. Crinò, P. Bruzzi, A. Ardizzoni, 1993, European journal of cancer.

The Role of Vindesine and Lonidamine in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer: A Phase III Randomized Fonicap Trial

M. Rinaldi, F. de Marinis, G. Altavilla, 1999, Tumori.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

M. Link, G. Boriani, J. Daubert, 2007, JAMA.

Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial

P. Bruzzi, V. Villanacci, L. Bonelli, 2013, Journal of Gastroenterology.

Attributable risks for oesophageal cancer in northern Italy.

C. la Vecchia, E. Negri, S. Franceschi, 1992, European journal of cancer.

Breast cancer incidence trends in European women aged 20–39 years at diagnosis

A. Fucic, P. Bruzzi, A. Znaor, 2012, Breast Cancer Research and Treatment.

The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits.

M. Sormani, P. Bruzzi, M. Bellini, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)

E. Vasile, V. Torri, P. Bruzzi, 2016, ESMO Open.

Palliative home care and place of death among cancer patients: a population-based study

P. Bruzzi, F. Henriquet, Massimo Costantini, 1993, Palliative medicine.

Clinical Application of Micronucleus Test: A Case-Control Study on the Prediction of Breast Cancer Risk/Susceptibility

P. Bruzzi, C. Bolognesi, V. Gismondi, 2014, PloS one.

Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging: a common-sense integration of exercise tolerance and ischaemia severity

P. Bruzzi, G. Sambuceti, M. Bauckneht, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma

M. Costantini, P. Bruzzi, T. Prochilo, 2004, Cancer.

Epidemiological Approach to Breast Cancer Etiology

P. Bruzzi, 1985 .

Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia

C. Autore, P. Bruzzi, A. Branzi, 1994, Circulation.

Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).

L. Crinò, P. Bruzzi, F. Cognetti, 2008, Clinical breast cancer.

Short term increase in risk of breast cancer after full term pregnancy.

C. la Vecchia, E. Negri, M. R. del Turco, 1988, BMJ.

Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

C. Autore, B. Maron, P. Bruzzi, 2009, Circulation.

Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey.

M. Costantini, P. Bruzzi, M. Montella, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study

P. Bruzzi, M. Ceppi, M. Lambertini, 2017, Oncotarget.

Molecular epidemiology: new rules for new tools?

M. Sormani, P. Bruzzi, D. Merlo, 2006, Mutation research.

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy

S. Ricci, C. Orlandini, P. Bruzzi, 2004, British Journal of Cancer.

Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.

P. Bruzzi, O. Garrone, G. Bertelli, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

sarcomaFull-dose neoadjuvant anthracycline + ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized trial

J. Blay, J. Coindre, P. Bruzzi, 2016 .

Impact of insulin resistance (IR) on the prognosis of metastatic breast cancer (MBC) patients treated with first-line chemotherapy (CT).

O. Nanni, D. Amadori, P. Bruzzi, 2014 .

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis

Gianmario Sambuceti, Michele Piana, Annalisa Perasso, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Outcome of Follow-Up Programs in Patients Previously Resected for Colorectal Cancer

P. Bruzzi, L. Santi, L. Bonelli, 1984, Tumori.

Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer

P. Bruzzi, S. Ravera, G. Sambuceti, 2016, Scientific Reports.

Innovation in oncology clinical trial design.

F. Bretz, I. Radtke, F. Bretz, 2019, Cancer treatment reviews.

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

O. Nanni, D. Amadori, L. Cavanna, 2018, Breast Cancer Research and Treatment.

The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis

M. Filippi, G. Comi, P. Bruzzi, 2005, Multiple sclerosis.

The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis

A. Thompson, M. Filippi, C. Pozzilli, 2005, Journal of Neurology.

Neuroblastoma Under One Year of Age1

A. Acquaviva, A. Donfrancesco, P. Bruzzi, 1990 .

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

J A Frank, J S Wolinsky, P S Tofts, 1998, Annals of neurology.

Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer.

P. Bruzzi, G. Canavese, M. Gipponi, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.

G. Scagliotti, S. Novello, L. Crinò, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Population attributable risk for endometrial cancer in northern Italy.

C. la Vecchia, E. Negri, P. Bruzzi, 1989, European journal of cancer & clinical oncology.

MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-1b

M Filippi, M. Filippi, L. Kappos, 2003, Neurology.

MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients

M. Filippi, G. Comi, P. Bruzzi, 2002, Neurology.

Can we measure long-term treatment effects in multiple sclerosis?

M. Sormani, P. Bruzzi, 2015, Nature Reviews Neurology.

Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes.

P. Bruzzi, B. Dozin, G. Canavese, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Selection of High-Risk Groups for Breast Cancer Screening. Evidence from an Italian Multicentric Case Control Study

M. R. del Turco, P. Bruzzi, D. Palli, 1988, Tumori.

A meta-analysis of chemotherapy duration in metastatic breast cancer (MBC)

O. Nanni, M. Stockler, M. Sormani, 2008 .

Multicenter randomised trial of paclitaxel (P) maintenance chemotherapy (CT) versus control in metastatic breast cancer (MBC) patients achieving a response or stable disease to first-line CT including anthracyclines and paclitaxel: Final results from the Italian MANTA study

O. Nanni, D. Amadori, C. Boni, 2005 .

The impact of mammography on breast cancer detection.

C. la Vecchia, E. Negri, S. Franceschi, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Surrogate endpoints for EDSS worsening in multiple sclerosis

L. Roccatagliata, P. Bruzzi, L. Bonzano, 2010, Neurology.

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.

C. Tibaldi, P. Bruzzi, O. Garrone, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distal hyperplastic polyps do not predict proximal adenomas: results from a multicentric study of colorectal adenomas.

M. Costantini, P. Bruzzi, G. Castiglione, 1997, Gastrointestinal endoscopy.

Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.

C. Boni, P. Bruzzi, G. Cocconi, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.

S. Fox, A. Harris, P. Bruzzi, 2006, Endocrine-related cancer.

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.

A. Ballestrero, P. Bruzzi, F. Puglisi, 2021, The Lancet. Oncology.

Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.

P. Bruzzi, M. Venturini, B. Dozin, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

A new prognostic and predictive tool for shared decision making in stage III colon cancer.

A. Shields, P. Bruzzi, A. Grothey, 2020, European journal of cancer.

The urgent need to improve the tools to assess clinical benefit and value of cancer treatment.

P. Bruzzi, G. Bregni, A. Sobrero, 2017, European journal of cancer.

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.

P. Bruzzi, V. Lorusso, A. Bottini, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anthropometric variables and risk of breast cancer

E. Negri, P. Boyle, P. Bruzzi, 1990, International journal of cancer.

Abstract P5-14-04: Effects of dose-dense chemotherapy on recurrence and cause-specific mortality in women with early breast cancer: A meta-analysis of individual patient data from randomised trials

R. Gray, R. Peto, L. Norton, 2017 .

The Complementary Role of Primary Prevention, Early Detection, and Therapy in Our Fight Against Cancer

S. Parodi, P. Bruzzi, L. Santi, 1987, Toxicologic pathology.

Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.

P. Bruzzi, P. Maineri, G. Ratto, 2004, The Annals of thoracic surgery.

Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial

L. Baglietto, P. Bruzzi, S. Bruno, 2000, Journal of cellular biochemistry.

Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer

M. Sormani, P. Bruzzi, F. Zanconati, 2013, International journal of molecular sciences.

Intermediate endpoints of primary systemic therapy in breast cancer patients.

P. Bruzzi, D. Generali, M. Brizzi, 2011, Journal of the National Cancer Institute. Monographs.

Planning of a screening programme for cervical cancer in liguria and evaluation of the attitude of the female population towards cancer detection

P. Bruzzi, L. Santi, L. Bonelli, 2004, European Journal of Epidemiology.

Do patients with rectosigmoid adenomas 5 mm or less in diameter need total colonoscopy?

M. Costantini, P. Bruzzi, G. Castiglione, 1999, Gastrointestinal endoscopy.

Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma

C. Boni, P. Bruzzi, G. Cocconi, 2002, Cancer.

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis

M. Sormani, D. Li, P. Bruzzi, 2011, Neurology.

Tamoxifen for the prevention of breast cancer

P. Bruzzi, 1998, BMJ.

Arena Quality of life assessment and clinical decision-making *

M. Costantini, P. Bruzzi, P. Casali, 2005 .

Wolfe's mammographic patterns in women with gross cystic disease of the breast.

M. Costantini, P. Bruzzi, L. Dogliotti, 1995, Journal of clinical epidemiology.

Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets

F. Barkhof, M. Rovaris, M. Filippi, 2001, Journal of neurology, neurosurgery, and psychiatry.

Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT

P. Bruzzi, G. Sambuceti, M. Bauckneht, 2017, Journal of Nuclear Cardiology.

Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis

M. Sormani, M. Inglese, P. Bruzzi, 1998, Neurology.

3346 BeyPro1: a Phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with Vemurafenib, with the association of Vemurafenib plus Fotemustine

P. Ascierto, E. Simeone, P. Bruzzi, 2015 .

BeyPro1: A phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with vemurafenib, with the association of vemurafenib plus fotemustine.

P. Ascierto, E. Simeone, P. Bruzzi, 2014 .

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

P. Bruzzi, M. Attanasio, G. Cabibbo, 2020, Cancers.

Treatment with aromatase inhibitors and markers of cardiovascular disease

P. Bruzzi, D. Palombo, M. Lambertini, 2016, Breast Cancer Research and Treatment.

Screening women at intermediate risk: harm or charm?

M. Bazzocchi, D. Caramella, P. Bruzzi, 2012, European journal of radiology.

Reporting of subgroup analyses from clinical trials

M. Sormani, P. Bruzzi, 2012, The Lancet Neurology.

Association between expression of insulin resistance (IR) related genes and breast cancer outcome

M. Sormani, P. Iozzo, P. Bruzzi, 2007 .

A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.

P. Bruzzi, M. Guenzi, B. Dozin, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer.

P. Bruzzi, A. Sobrero, L. Gallo, 1992, European journal of cancer.

The Di Bella multitherapy trial. Criticism ignores standard methodology of cancer treatments.

P. Bruzzi, G. Benagiano, R. Raschetti, 1999, BMJ.

The unconventional Di Bella cancer treatment

P. Bruzzi, M. Maggini, D. Greco, 1999, Cancer.

No standard treatment is available for advanced pancreatic cancer.

P. Bruzzi, R. Rosso, R. Lionetto, 1995, European journal of cancer.

Age at first and second births and breast cancer risk in biparous women

N. Day, C. la Vecchia, E. Negri, 1990, International journal of cancer.

Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.

M. Senni, B. Maron, P. Bruzzi, 2015, Journal of the American College of Cardiology.

Lack of Activity of Docetaxel in Soft Tissue Sarcomas: Results of a Phase II Study of the Italian Group on Rare Tumors

P. Bruzzi, A. Santoro, L. Dogliotti, 1999, Sarcoma.

A Multicenter Study of Colorectal Adenomas Rationale, Objectives, Methods and Characteristics of the Study Cohort

P. Bruzzi, 1995, Tumori.

Univariate and multivariate analyses of the relationship between adenocarcinoma and solitary and multiple adenomas in colorectal adenoma patients

M. Costantini, P. Bruzzi, G. Nicolò, 1991, International journal of cancer.

Abstract P6-09-01: Breast Cancer Incidence and Hormonal Infertility Treatments: A Systematic Review of Population Studies

P. Bruzzi, A. Censi, M. Puntoni, 2010 .

Self-perceived normality in defecation habits.

M. Sormani, P. Bruzzi, M. Bellini, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

"Normal values" for the lymphocyte cytokinesis-block micronucleus cytome parameters: Repeatability and reproducibility in a healthy reference population.

P. Bruzzi, C. Bolognesi, L. Bonelli, 2019, The Science of the total environment.

Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study

P. Bruzzi, C. Viscoli, A. Marchese, 2017, European Journal of Clinical Microbiology and Infectious Diseases.

START: a European state-of-the-art on-line instrument for clinical oncologists.

F. Cavalli, F. D. De Braud, P. Bruzzi, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

HM35 Role of temporary ovarian suppression obtained with GnRH analogue in reducing premature ovarian failure induced by chemotherapy in premenopausal cancer patients: a meta-analysis of randomized studies

P. Bruzzi, M. Lambertini, F. Poggio, 2012 .

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib

P. Ascierto, E. Simeone, P. Bruzzi, 2016, OncoTarget.

The management of achondroplasia in Italy: results from a Delphi panel based on real-world experience

M. Maghnie, G. Scarano, P. Bruzzi, 2023, Frontiers in Pediatrics.